Michael Nemzek joins Velocity11 of Menlo Park, Calif., as vice president of marketing, the company said this week. Nemzek previously was general manager of discovery tools at Symyx Technologies. Prior to that, Nemzek was an executive with Cellomics; Genosys Biotechnologies (now part of Sigma-Aldrich); Tropix, now part of Applied Biosystems; and EG&G, now part of PerkinElmer. Velocity11 develops automation technologies for pharma/biotech and genomics labs.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.